Literature DB >> 23686350

International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligands.

Anthony P Davenport1, Stephen P H Alexander, Joanna L Sharman, Adam J Pawson, Helen E Benson, Amy E Monaghan, Wen Chiy Liew, Chidochangu P Mpamhanga, Tom I Bonner, Richard R Neubig, Jean Philippe Pin, Michael Spedding, Anthony J Harmar.   

Abstract

In 2005, the International Union of Basic and Clinical Pharmacology Committee on Receptor Nomenclature and Drug Classification (NC-IUPHAR) published a catalog of all of the human gene sequences known or predicted to encode G protein-coupled receptors (GPCRs), excluding sensory receptors. This review updates the list of orphan GPCRs and describes the criteria used by NC-IUPHAR to recommend the pairing of an orphan receptor with its cognate ligand(s). The following recommendations are made for new receptor names based on 11 pairings for class A GPCRs: hydroxycarboxylic acid receptors [HCA₁ (GPR81) with lactate, HCA₂ (GPR109A) with 3-hydroxybutyric acid, HCA₃ (GPR109B) with 3-hydroxyoctanoic acid]; lysophosphatidic acid receptors [LPA₄ (GPR23), LPA₅ (GPR92), LPA₆ (P2Y5)]; free fatty acid receptors [FFA4 (GPR120) with omega-3 fatty acids]; chemerin receptor (CMKLR1; ChemR23) with chemerin; CXCR7 (CMKOR1) with chemokines CXCL12 (SDF-1) and CXCL11 (ITAC); succinate receptor (SUCNR1) with succinate; and oxoglutarate receptor [OXGR1 with 2-oxoglutarate]. Pairings are highlighted for an additional 30 receptors in class A where further input is needed from the scientific community to validate these findings. Fifty-seven human class A receptors (excluding pseudogenes) are still considered orphans; information has been provided where there is a significant phenotype in genetically modified animals. In class B, six pairings have been reported by a single publication, with 28 (excluding pseudogenes) still classified as orphans. Seven orphan receptors remain in class C, with one pairing described by a single paper. The objective is to stimulate research into confirming pairings of orphan receptors where there is currently limited information and to identify cognate ligands for the remaining GPCRs. Further information can be found on the IUPHAR Database website (http://www.iuphar-db.org).

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23686350      PMCID: PMC3698937          DOI: 10.1124/pr.112.007179

Source DB:  PubMed          Journal:  Pharmacol Rev        ISSN: 0031-6997            Impact factor:   25.468


  235 in total

1.  Characterization of an orphan G protein-coupled receptor localized in the dorsal root ganglia reveals adenine as a signaling molecule.

Authors:  Eckhard Bender; Arjan Buist; Mirek Jurzak; Xavier Langlois; Geert Baggerman; Peter Verhasselt; Martine Ercken; Hong-Qing Guo; Cindy Wintmolders; Ilse Van den Wyngaert; Irma Van Oers; Liliane Schoofs; Walter Luyten
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-25       Impact factor: 11.205

Review 2.  Pharmacological characterization of GPR55, a putative cannabinoid receptor.

Authors:  Haleli Sharir; Mary E Abood
Journal:  Pharmacol Ther       Date:  2010-03-16       Impact factor: 12.310

3.  GPR92 as a new G12/13- and Gq-coupled lysophosphatidic acid receptor that increases cAMP, LPA5.

Authors:  Chang-Wook Lee; Richard Rivera; Shannon Gardell; Adrienne E Dubin; Jerold Chun
Journal:  J Biol Chem       Date:  2006-06-14       Impact factor: 5.157

4.  Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake.

Authors:  Jian V Zhang; Pei-Gen Ren; Orna Avsian-Kretchmer; Ching-Wei Luo; Rami Rauch; Cynthia Klein; Aaron J W Hsueh
Journal:  Science       Date:  2005-11-11       Impact factor: 47.728

Review 5.  Lysophospholipid receptors: signalling, pharmacology and regulation by lysophospholipid metabolism.

Authors:  Dagmar Meyer zu Heringdorf; Karl H Jakobs
Journal:  Biochim Biophys Acta       Date:  2006-10-04

6.  Micromolar concentration of kynurenic acid in rat small intestine.

Authors:  D Kuc; W Zgrajka; J Parada-Turska; T Urbanik-Sypniewska; W A Turski
Journal:  Amino Acids       Date:  2008-01-31       Impact factor: 3.520

7.  Role of LPA4/p2y9/GPR23 in negative regulation of cell motility.

Authors:  Zendra Lee; Ching-Ting Cheng; Helen Zhang; Mark A Subler; Jinhua Wu; Abir Mukherjee; Jolene J Windle; Ching-Kang Chen; Xianjun Fang
Journal:  Mol Biol Cell       Date:  2008-10-08       Impact factor: 4.138

8.  Influence of dietary fatty acids on endocannabinoid and N-acylethanolamine levels in rat brain, liver and small intestine.

Authors:  Andreas Artmann; Gitte Petersen; Lars I Hellgren; Julie Boberg; Christian Skonberg; Christine Nellemann; Steen Honoré Hansen; Harald S Hansen
Journal:  Biochim Biophys Acta       Date:  2008-02-12

9.  The GPR55 ligand L-alpha-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation.

Authors:  Christopher M Henstridge; Nariman A B Balenga; Lesley A Ford; Ruth A Ross; Maria Waldhoer; Andrew J Irving
Journal:  FASEB J       Date:  2008-08-29       Impact factor: 5.191

10.  The Mouse Genome Database (MGD): comprehensive resource for genetics and genomics of the laboratory mouse.

Authors:  Janan T Eppig; Judith A Blake; Carol J Bult; James A Kadin; Joel E Richardson
Journal:  Nucleic Acids Res       Date:  2011-11-10       Impact factor: 16.971

View more
  104 in total

Review 1.  Identifying ligands at orphan GPCRs: current status using structure-based approaches.

Authors:  Tony Ngo; Irina Kufareva; James Lj Coleman; Robert M Graham; Ruben Abagyan; Nicola J Smith
Journal:  Br J Pharmacol       Date:  2016-03-05       Impact factor: 8.739

Review 2.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

3.  Evolving pharmacology of orphan GPCRs: IUPHAR Commentary.

Authors:  Anthony P Davenport; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-10       Impact factor: 8.739

Review 4.  Significance of angiotensin 1-7 coupling with MAS1 receptor and other GPCRs to the renin-angiotensin system: IUPHAR Review 22.

Authors:  Sadashiva S Karnik; Khuraijam Dhanachandra Singh; Kalyan Tirupula; Hamiyet Unal
Journal:  Br J Pharmacol       Date:  2017-03-09       Impact factor: 8.739

5.  Resolvin E1 for reducing vascular calcification.

Authors:  Neil MacRitchie; Pasquale Maffia
Journal:  Cardiovasc Res       Date:  2019-08-01       Impact factor: 10.787

Review 6.  Endocannabinoid signaling pathways: beyond CB1R and CB2R.

Authors:  Roger Gregory Biringer
Journal:  J Cell Commun Signal       Date:  2021-05-12       Impact factor: 5.782

7.  A dynamic and screening-compatible nanoluciferase-based complementation assay enables profiling of individual GPCR-G protein interactions.

Authors:  Céline Laschet; Nadine Dupuis; Julien Hanson
Journal:  J Biol Chem       Date:  2018-12-28       Impact factor: 5.157

Review 8.  Update on leukotriene, lipoxin and oxoeicosanoid receptors: IUPHAR Review 7.

Authors:  Magnus Bäck; William S Powell; Sven-Erik Dahlén; Jeffrey M Drazen; Jilly F Evans; Charles N Serhan; Takao Shimizu; Takehiko Yokomizo; G Enrico Rovati
Journal:  Br J Pharmacol       Date:  2014-07-12       Impact factor: 8.739

9.  Research resource: Gene profiling of G protein-coupled receptors in the arcuate nucleus of the female.

Authors:  Oline K Rønnekleiv; Yuan Fang; Chunguang Zhang; Casey C Nestor; Peizhong Mao; Martin J Kelly
Journal:  Mol Endocrinol       Date:  2014-06-16

10.  The chemerin knockout rat reveals chemerin dependence in female, but not male, experimental hypertension.

Authors:  Stephanie W Watts; Emma S Darios; Adam E Mullick; Hannah Garver; Thomas L Saunders; Elizabeth D Hughes; Wanda E Filipiak; Michael G Zeidler; Nichole McMullen; Christopher J Sinal; Ramya K Kumar; David J Ferland; Gregory D Fink
Journal:  FASEB J       Date:  2018-06-15       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.